No definition available.
Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
C3_THYROID_GLAND_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
2963 |
4. Check minimum number of eventsNone |
2963 |
5. Include endpointsNone |
2963 |
6. Filter based on genotype QC (FinnGen only) |
2963 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
- Malignant neoplasm of thyroid gland
- Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
- Papillary adenocarcinoma of thyroid gland
- Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
- Follicular adenocarcinoma of thyroid gland
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2963 | 2192 | 771 |
| Unadjusted period prevalence (%) | 0.64 | 0.75 | 0.34 |
| Median age at first event (years) | 51.48 | 49.10 | 58.26 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2400
- Matched controls
- 24008
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EP1AE
NOMESCO Finland
Neck ultrasound examination
50.7
323.0
1197
462
BAA60
NOMESCO Finland
Total thyroidectomy
163.9
323.0
1350
187
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
323.0
357
*
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
191.6
323.0
676
49
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
3358.5
323.0
306
*
104
Kela drug reimbursment
Thyroid insufficiency
73.6
323.0
1807
952
H03AA01
ATC
levothyroxine sodium; systemic
94.0
323.0
2281
4035
ZX114
NOMESCO Finland
Intramuscular
47.5
323.0
418
106
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
77.6
323.0
701
127
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
31.9
323.0
544
218
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
98.6
323.0
650
90
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
323.0
1816
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.6
323.0
1415
4882
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
4503599627370496.0
323.0
1877
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
323.0
342
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
323.0
620
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
312.5
293
*
4CJ01
NOMESCO Finland
NA
+∞
309.2
290
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
299.4
281
*
130
Kela drug reimbursment
Malignant tumour
+∞
287.4
270
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
31.3
250.4
338
125
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
221.3
209
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
213.8
202
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
30.1
206.4
281
105
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
206.3
195
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
200.9
190
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
9.2
166.4
372
471
T71
ICPC
Malignant neoplasm thyroid
+∞
164.5
156
*
115
Kela drug reimbursment
Breast cancer
+∞
164.5
156
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
111.4
153.2
166
16
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
53.1
151.7
182
37
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
90.3
151.4
168
20
2506
FHL
Thyroidectomy
201.2
146.5
151
8
H02AB02
ATC
dexamethasone; systemic
23.0
145.1
213
101
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
137.8
887
3559
A11CC03
ATC
alfacalcidol; systemic
14.7
137.4
238
178
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
136.8
130
*
106
Kela drug reimbursment
Hypoparathyroidism
83.6
133.0
149
19
PJA12
NOMESCO Finland
Sentinel node biopsy
284.3
132.6
134
5
Z51.88
ICD-10 Finland
Other specified medical care
17.4
123.7
200
125
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.5
123.7
702
2518
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
122.1
928
4112
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
+∞
119.8
114
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
117.7
112
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
110.2
105
*
WX402
NOMESCO Finland
General anaesthesia
3.7
109.1
554
1791
A04AA02
ATC
granisetron; systemic, transdermal
109.7
106.0
115
11
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
13.6
103.8
185
146
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
73.9
99.3
113
16
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
14.4
98.9
172
128
C739
ICD-10 Finland
NA
+∞
98.6
94
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
94.4
90
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
93.3
89
*
8340/3-C73.9
ICD-O-3
Papillary carcinoma, follicular variant of thyroid gland
+∞
93.3
89
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
87.9
90.8
101
12
C61
ICD-10 Finland
Malignant neoplasm of prostate
900.7
89.3
87
*
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
8.8
88.1
197
241
WF002
NOMESCO Finland
Radical radiotherapy
72.0
85.0
97
14
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
23.7
84.4
122
54
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
83.8
80
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
82.8
79
*
JN4BD
NOMESCO Finland
Extensive body CT
6.2
82.4
237
419
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
24.4
79.6
114
49
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
36.7
79.2
102
29
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
82.1
77.6
87
11
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
76.4
73
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
75.4
72
*
A11CC02
ATC
dihydrotachysterol; oral
68.5
74.9
86
13
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.7
72.2
194
312
HAC20
NOMESCO Finland
Total mastectomy
130.7
71.3
76
6
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
362.6
71.0
71
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.3
70.8
229
465
L02BA01
ATC
tamoxifen; oral
152.6
70.3
74
5
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
70.1
67
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
69.1
66
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
68.0
65
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
121.9
66.2
71
6
E83.51
ICD-10 Finland
Hypocalcemia
25.5
64.6
91
37
L03AA13
ATC
pegfilgrastim; parenteral
644.8
64.2
63
*
A12AA04
ATC
calcium carbonate; oral
12.2
59.8
111
95
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
59.5
438
1768
HA1AA
NOMESCO Finland
X-ray mammography
5.6
57.5
177
338
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.2
57.2
236
613
C73.94
ICD-10 Finland
Medullary thyroid carcinoma (thyroid)
+∞
56.5
54
*
GD1AD
NOMESCO Finland
Thorax CT examination
6.3
56.4
157
264
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.1
56.1
159
274
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
288.0
55.4
56
*
JN5SN
NOMESCO Finland
NA
+∞
54.4
52
*
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
54.7
54.0
64
12
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
277.0
53.4
54
*
JN4AD
NOMESCO Finland
Body CT examination
5.9
52.8
155
279
WZC30
NOMESCO Finland
Teaching
3.1
51.9
322
1155
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
518.7
51.6
51
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
51.2
49
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
260.7
50.3
51
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
19.1
49.4
76
41
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
63.6
48.4
56
9
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
19.8
48.1
73
38
C50.99
ICD-10 Finland
Breast, unspecified
+∞
48.1
46
*
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
15.9
46.8
77
50
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
46.3
265
894
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
239.5
46.1
47
*
A12AA06
ATC
calcium lactate gluconate; oral
76.0
46.1
52
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.0
46.1
118
177
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
46.0
44
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
44.9
43
*
116
Kela drug reimbursment
Prostate cancer
+∞
44.9
43
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
122.4
44.9
48
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
229.1
44.1
45
*
WW200
NOMESCO Finland
Immunization
6.0
43.9
126
220
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.3
42.0
162
393
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
41.8
40
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
41.8
40
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
41.8
40
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
145.8
40.9
43
*
Z51.5
ICD-10 Finland
Palliative care
8.2
40.6
93
118
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
39.4
957
6414
C73.93
ICD-10 Finland
Anaplastic thyroid carcinoma (thyroid)
+∞
38.6
37
*
ZXA10
NOMESCO Finland
Bilateral
2.1
37.8
498
2646
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
37.6
36
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
37.6
36
*
A04AA01
ATC
ondansetron; systemic, rectal
5.0
37.2
125
263
L02BG04
ATC
letrozole; oral
6.8
35.9
93
142
WX704
NOMESCO Finland
Intubation
3.0
35.9
217
758
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
10.7
35.9
70
67
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
7.5
35.8
86
118
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
48.6
35.7
43
9
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
28.8
35.6
48
17
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.0
35.5
148
386
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
35.5
34
*
N02BE01
ATC
paracetamol; systemic, rectal
2.0
35.5
2046
17799
JN6AD
NOMESCO Finland
CT of torso and neck
20.0
35.3
53
27
ZXA05
NOMESCO Finland
Left side
1.9
35.2
604
3556
8290/3-C73.9
ICD-O-3
Oxyphilic adenocarcinoma of thyroid gland
+∞
34.4
33
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
34.4
33
*
T86
ICPC
Hypothyroidism/myxoedema
3.7
34.1
158
452
BAA99
NOMESCO Finland
Other operation on thyroid gland
75.2
32.9
37
5
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
32.4
31
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
321.1
31.9
32
*
L01BC06
ATC
capecitabine; oral
+∞
31.3
30
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
31.3
30
*
198
Kela drug reimbursment
Sorafenib
+∞
31.3
30
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
31.3
30
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
25.7
31.0
43
17
L03AA02
ATC
filgrastim; parenteral
42.8
30.9
38
9
GD6AD
NOMESCO Finland
CT of chest and neck
42.8
30.9
38
9
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
162.0
30.7
32
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
306.0
29.9
30
*
ZX080
NOMESCO Finland
Image guided radiotherapy
306.0
29.9
30
*
BA1AQ
NOMESCO Finland
Thyroid SPECT with low dose CT
306.0
29.9
30
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
7.0
29.1
73
107
ZXA00
NOMESCO Finland
Right side
1.8
28.4
616
3881
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
28.2
27
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
28.2
27
*
8510/3-C73.9
ICD-O-3
Medullary carcinoma, NOS, of thyroid gland
+∞
28.2
27
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
28.2
27
*
N02AA05
ATC
oxycodone; systemic
2.4
28.1
263
1180
ZSB00
NOMESCO Finland
Procedure related to previous procedure classified in chapter B
78.6
27.8
31
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
13.6
27.7
48
36
JN4CD
NOMESCO Finland
Very extensive body CT
6.5
27.4
72
113
8345/3-C73.9
ICD-O-3
Medullary thyroid carcinoma of thyroid gland
+∞
27.1
26
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
27.1
26
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
38.3
27.1
34
9
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.4
26.5
135
416
B01AB05
ATC
enoxaparin; parenteral
1.7
26.3
633
4104
XX1MN
NOMESCO Finland
Isotope examination with measurement
+∞
26.1
25
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
26.1
25
*
A79
ICPC
Malignancy NOS
263.3
25.7
26
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
25.7
523
3212
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
136.4
25.6
27
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
10.6
25.3
49
47
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
22.8
25.2
36
16
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
8.1
25.2
57
72
E8901, C7391
ICD-10 Finland
NA
+∞
25.0
24
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
70.6
24.8
28
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
21.5
24.8
36
17
A04AD12
ATC
aprepitant; systemic
131.3
24.6
26
*
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
6.3
24.6
66
107
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
24.0
23
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
24.0
23
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
24.0
23
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
13.4
23.7
41
31
L03AA14
ATC
lipegfilgrastim; parenteral
242.2
23.7
24
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.4
23.1
51
62
323
Kela drug reimbursment
Sorafenib
+∞
22.9
22
*
L02BG03
ATC
anastrozole; oral
45.4
22.4
27
6
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.4
22.3
82
191
2504
FHL
Unilateral resection or enucleation
8.0
22.0
50
64
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
15.2
22.0
36
24
8000/3-C73.9
ICD-O-3
Neoplasm, malignant of thyroid gland
+∞
21.9
21
*
WA039
NOMESCO Finland
Radiotherapy with free isotopes
+∞
21.9
21
*
X76
ICPC
Malignant neoplasm breast female
221.9
21.6
22
*
Y77
ICPC
Malignant neoplasm prostate
116.1
21.6
23
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
116.1
21.6
23
*
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
43.7
21.4
26
6
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
21.2
429
2615
TQW20
NOMESCO Finland
Tatoe
50.5
21.1
25
5
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
4.8
21.0
71
152
8020/3-C73.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of thyroid gland
+∞
20.9
20
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
20.9
20
*
L01XE05
ATC
[U] sorafenib; oral
+∞
20.9
20
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
20.9
20
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
111.0
20.6
22
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
7.8
20.1
46
60
Z31.5
ICD-10 Finland
Genetic counselling
3.1
19.9
115
389
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.4
19.8
99
302
3019
Kela drug reimbursment
Lenvatinib
+∞
19.8
19
*
BA2MN
NOMESCO Finland
Thyroid radiation dose measurement during isotope therapy
+∞
19.8
19
*
1508
Kela drug reimbursment
Lenvatinib
+∞
19.8
19
*
1930X
ICD-9 Finland
Malignant neoplasm of thyroid gland[NEOPLASMA MALIGNUM THYREOIDEAE EI HISTOL VAHV]
+∞
19.8
19
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
19.8
19
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
74.1
19.7
22
*
BA2AT
NOMESCO Finland
Biopsy of thyroid with ultrasound quidance
74.1
19.7
22
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
74.1
19.7
22
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
21.8
19.5
28
13
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
46.4
19.2
23
5
WX725
NOMESCO Finland
Noninvasive ventilation
2.8
18.9
123
448
8010/3-C73.9
ICD-O-3
Carcinoma, NOS, of thyroid gland
+∞
18.8
18
*
1930B
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]
+∞
18.8
18
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
13.5
18.7
32
24
E20.8
ICD-10 Finland
Other hypoparathyroidism
70.4
18.7
21
*
JN5AN
NOMESCO Finland
Total body isotope imaging
191.4
18.6
19
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
191.4
18.6
19
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
191.4
18.6
19
*
S18
ICPC
Laceration/cut
1.5
18.0
850
6420
R49.01
ICD-10 Finland
Functional dysphonia
3.2
17.8
95
305
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
17.7
17
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
17.7
17
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
17.7
17
*
L02BG06
ATC
exemestane; oral
+∞
17.7
17
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
17.7
17
*
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
29.0
17.4
23
8
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
3.0
17.3
100
339
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
31.7
17.0
22
7
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
50.4
17.0
20
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
25.8
16.9
23
9
EP1DM
NOMESCO Finland
Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet
63.8
16.7
19
*
1AB01
NOMESCO Finland
NA
+∞
16.7
16
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
16.7
16
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
16.7
16
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.6
16.7
76
217
H03BB01
ATC
carbimazole; oral
2.6
16.6
122
482
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
171.1
16.5
17
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
7.6
16.4
38
51
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
40.3
16.3
20
5
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
30.2
16.1
21
7
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
60.4
15.8
18
*
L02BB03
ATC
bicalutamide; oral
+∞
15.6
15
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
15.6
15
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
15.6
15
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
15.5
126
526
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
161.0
15.5
16
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.1
15.3
48
96
J01DB01
ATC
cefalexin; oral
1.5
15.1
1844
16573
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
6.3
14.9
39
63
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
31.9
14.8
19
6
B01AB10
ATC
tinzaparin; parenteral
2.6
14.8
108
426
Z50.5
ICD-10 Finland
Speech therapy
5.1
14.7
46
92
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
10.5
14.7
28
27
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
14.6
14
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
14.6
14
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
14.6
14
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
14.6
14
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
14.6
14
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
80.6
14.6
16
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
14.5
297
1800
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
5.7
14.5
41
73
XX9XW
NOMESCO Finland
NA
8.5
14.5
31
37
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
150.8
14.5
15
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
42.7
14.1
17
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
14.0
106
425
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.4
13.9
122
531
C90.0
ICD-10 Finland
Multiple myeloma
53.6
13.8
16
*
E03
ICD-10 Finland
Other hypothyroidism
2.1
13.8
155
757
R13
ICD-10 Finland
Dysphagia
2.1
13.6
150
726
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
75.5
13.6
15
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
14.8
13.6
22
15
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
13.5
13
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
13.5
13
*
L01XE29
ATC
[U] lenvatinib; oral
+∞
13.5
13
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
13.5
13
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
13.5
13
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
13.5
13
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
13.5
13
*
BAA30
NOMESCO Finland
Excision of thyroid isthmus
34.2
13.5
17
5
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
140.7
13.5
14
*
WX400
NOMESCO Finland
Inhalation anesthesy
2.5
13.4
105
429
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
21.3
13.3
19
9
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
10.5
13.2
25
24
SPAT1153
SPAT
Removal of sutures
1.5
13.2
642
4811
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
2.8
13.1
83
302
XW000
NOMESCO Finland
Bone marrow biopsy
3.1
13.1
72
239
ZX050
NOMESCO Finland
Stereotactic radiotherapy
22.6
12.9
18
8
R49.08
ICD-10 Finland
Other specified dysphonia
3.1
12.8
70
231
XKD00
NOMESCO Finland
Uroflowmetry
1.9
12.8
197
1090
ZX112
NOMESCO Finland
Subcutaneous
5.8
12.7
35
61
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
12.6
311
1985
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
11.0
12.5
23
21
XX1XN
NOMESCO Finland
Other isotope examination
+∞
12.5
12
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
12.5
12
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
12.5
12
*
L02BX02
ATC
degarelix; parenteral
+∞
12.5
12
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
12.5
12
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
12.5
171
903
2410A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic uninodular goitre
10.1
12.5
24
24
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
130.6
12.4
13
*
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
4.2
12.3
46
112
WX720
NOMESCO Finland
Own respiration
2.5
12.2
92
372
R4110
NOMESCO Finland
Physiotherapy
1.5
12.1
503
3641
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
26.8
12.0
16
6
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
12.0
133
647
2260A
ICD-9 Finland
Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]
14.7
11.8
19
13
ENB50
NOMESCO Finland
Excision of cyst or fistula of thyroglossic duct
30.2
11.6
15
5
GAB20
NOMESCO Finland
Median sternotomy
65.2
11.6
13
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
11.6
234
1411
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
11.5
11
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
11.5
11
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
11.5
11
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
11.5
11
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
11.5
11
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
11.5
11
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
120.5
11.4
12
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.0
11.3
152
798
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.7
11.3
37
79
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
35.2
11.3
14
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
8.9
11.2
23
26
L02AE02
ATC
leuprorelin; implant, parenteral
4.4
11.2
39
89
WX110
NOMESCO Finland
Local anesthesy
1.3
11.2
1472
12965
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
12.8
11.1
19
15
4701
FHL
Neck lymph node removal
20.1
11.1
16
8
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
43.5
10.9
13
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.9
10.8
26
38
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
12.0
10.8
19
16
D25.1
ICD-10 Finland
Intramural leiomyoma of uterus
2.0
10.7
143
750
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
60.2
10.6
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.3
10.4
51
157
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
110.5
10.4
11
*
XX1AD
NOMESCO Finland
Other CT-examination
110.5
10.4
11
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
10.4
10
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
10.4
10
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
10.4
10
*
8335/3-C73.9
ICD-O-3
Follicular carcinoma, minimally invasive of thyroid gland
+∞
10.4
10
*
1CD02
NOMESCO Finland
NA
+∞
10.4
10
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
10.4
10
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
10.4
10
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
10.4
10
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
10.4
10
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
10.4
10
*
HAB99
NOMESCO Finland
Other partial excision of mammary gland
4.4
10.4
36
82
RL210
NOMESCO Finland
NA
6.8
10.4
25
37
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
32.6
10.3
13
*
2397A
ICD-9 Finland
Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system
32.6
10.3
13
*
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
1.7
10.3
212
1285
ZZR10
NOMESCO Finland
Flap of skin and muscle
23.4
10.2
14
6
S77
ICPC
Malignant neoplasm of skin
23.4
10.2
14
6
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
10.2
203
1221
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
10.2
141
750
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
6.2
10.1
26
42
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
5.4
10.1
29
54
ZX120
NOMESCO Finland
Intravenous
1.9
10.0
144
777
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
16.8
9.9
15
9
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
4.4
9.8
34
78
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.5
9.7
24
37
GBB00
NOMESCO Finland
Tracheostomy
5.1
9.7
29
57
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.7
9.6
40
109
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.8
9.6
58
208
UDQ02
NOMESCO Finland
Direct laryngoscopy
4.8
9.5
30
63
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
100.4
9.4
10
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
9.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
9.4
9
*
L01CA04
ATC
vinorelbine; systemic
+∞
9.4
9
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
9.4
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
9.4
9
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
9.4
9
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
9.4
9
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
9.4
9
*
D09.3
ICD-10 Finland
Carcinoma in situ: Thyroid and other endocrine glands
+∞
9.4
9
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
9.4
9
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
9.4
9
*
2502
FHL
Thyroid exploration and possible biopsy
+∞
9.4
9
*
T85
ICPC
Hyperthyroidism/thyrotoxicosis
5.6
9.3
26
47
EP1AE
SPAT
NA
3.5
9.3
42
122
A06AH03
ATC
naloxegol; oral
10.7
9.3
17
16
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
9.3
822
6749
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
9.3
147
821
E21.0
ICD-10 Finland
Primary hyperparathyroidism
3.5
9.3
42
123
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
6.7
9.1
22
33
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.9
9.1
54
191
R4130
NOMESCO Finland
Speech therapy
2.9
9.0
53
186
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
36.8
9.0
11
*
H02AB09
ATC
hydrocortisone; systemic
3.0
8.9
48
160
S04
ICPC
Lump/swelling localized
1.7
8.9
182
1103
ZZF00
NOMESCO Finland
Graft of adipose tissue
8.0
8.8
19
24
ZXC96
NOMESCO Finland
Robot assisted procedure
5.1
8.8
26
51
N05CF01
ATC
zopiclone; oral
1.4
8.7
619
4902
UJF32
NOMESCO Finland
Coloscopy
1.4
8.7
474
3590
R50.9
ICD-10 Finland
Fever, unspecified
1.6
8.7
227
1472
UGB02
NOMESCO Finland
Tracheoscopy
14.1
8.7
14
10
J01MA12
ATC
levofloxacin; systemic
1.5
8.7
312
2177
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
50.2
8.7
10
*
WW500
NOMESCO Finland
Blood transfusion
2.8
8.7
53
192
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.0
8.6
47
158
UJC12
NOMESCO Finland
Flexible oesophagoscopy
7.6
8.6
19
25
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.1
8.6
45
147
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
5.5
8.6
24
44
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
11.6
8.6
15
13
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
3.9
8.5
33
85
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
8.5
129
710
KAC10
NOMESCO Finland
Total nephrectomy with capsule
20.1
8.5
12
6
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
90.3
8.4
9
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
90.3
8.4
9
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
90.3
8.4
9
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
90.3
8.4
9
*
HAE99
NOMESCO Finland
Other reconstruction of breast
12.8
8.4
14
11
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
8.3
8
*
C75
ICD-10 Finland
Malignant neoplasm of other endocrine glands and related structures
+∞
8.3
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.3
8
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
8.3
8
*
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
+∞
8.3
8
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
8.3
8
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
8.3
8
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
8.3
8
*
L01EX08
ATC
lenvatinib; oral
+∞
8.3
8
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
8.3
8
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
8.3
8
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
8.3
8
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.1
8.3
43
140
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
10.8
8.3
15
14
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.1
8.3
91
446
UJC01
NOMESCO Finland
Scopy of lower throat
4.8
8.2
26
55
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
2.1
8.2
94
465
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
8.2
152
895
A02BC02
ATC
pantoprazole; systemic
1.3
8.1
1352
12030
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
3.7
8.1
34
94
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.0
8.1
45
154
2509
FHL
Other measure in this category
33.4
8.1
10
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
8.1
2046
19319
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
8.0
136
778
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
8.0
259
1770
M05BX04
ATC
denosumab; parenteral
2.2
8.0
81
382
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
8.0
581
4610
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.1
8.0
29
71
R49.09
ICD-10 Finland
Unspecified dysphonia
3.9
7.8
30
77
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.6
7.8
33
92
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
8.5
7.8
16
19
B01AB04
ATC
dalteparin; parenteral
2.0
7.7
89
445
ZZR00
NOMESCO Finland
Flap of skin
5.9
7.7
20
34
J01MA02
ATC
ciprofloxacin; systemic
1.3
7.6
728
6004
P01AB01
ATC
metronidazole; oral, rectal
1.3
7.6
847
7131
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
25.1
7.6
10
*
DQE20
NOMESCO Finland
Implantation of foreign material in vocal chord
25.1
7.6
10
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
25.1
7.6
10
*
E83.50
ICD-10 Finland
Hypercalcemia
3.5
7.6
33
95
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
80.3
7.4
8
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
80.3
7.4
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
7.4
547
4346
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.9
7.4
99
524
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
7.7
7.4
16
21
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
13.4
7.4
12
9
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
13.4
7.4
12
9
KED22
NOMESCO Finland
Transurethral resection of prostate
2.4
7.3
59
251
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
7.3
7
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
7.3
7
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
7.3
7
*
L04AX04
ATC
lenalidomide; oral
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
7.3
7
*
9680/3-C73.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of thyroid gland
+∞
7.3
7
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
7.3
7
*
L02BA03
ATC
fulvestrant; parenteral
+∞
7.3
7
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
7.3
7
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
6.8
7.3
17
25
C07AA05
ATC
propranolol; systemic
1.4
7.2
396
2996
H01CB03
ATC
lanreotide; parenteral
30.1
7.1
9
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
30.1
7.1
9
*
T73
ICPC
Neoplasm endocrine other/unspecified
20.1
7.1
10
5
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.7
7.0
22
47
UDC00
NOMESCO Finland
Ear microscopy
1.7
7.0
141
853
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
6.9
149
918
J37.0
ICD-10 Finland
Chronic laryngitis
2.1
6.9
71
337
WX734
NOMESCO Finland
JET-ventilation
13.8
6.9
11
8
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
6.8
559
4503
E20
ICD-10 Finland
Hypoparathyroidism
40.2
6.8
8
*
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
40.2
6.8
8
*
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
3.0
6.7
36
122
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
5.5
6.6
18
33
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.0
6.6
35
118
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
12.3
6.6
11
9
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.8
6.5
39
141
WX002
NOMESCO Finland
Sedation and analgesia
1.4
6.5
351
2649
A02BC05
ATC
esomeprazole; systemic
1.3
6.5
842
7196
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
3.8
6.5
25
66
153
Kela drug reimbursment
Lenalidomid
70.0
6.4
7
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
70.0
6.4
7
*
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
70.0
6.4
7
*
128
Kela drug reimbursment
Cancers of female genital organs
70.0
6.4
7
*
2374A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Other and unspecified endocrine glands
70.0
6.4
7
*
329
Kela drug reimbursment
Lenalidomide
70.0
6.4
7
*
J01FA10
ATC
azithromycin; systemic
1.2
6.4
1249
11184
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.1
6.4
32
104
E04.8
ICD-10 Finland
Other specified nontoxic goitre
6.0
6.3
16
27
Q18.8
ICD-10 Finland
Other specified congenital malformations of face and neck
11.0
6.3
11
10
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
6.3
6
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
6.3
6
*
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
6.3
6
*
4707
FHL
Dissection Colli radicalis
+∞
6.3
6
*
9591/3-C73.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of thyroid gland
+∞
6.3
6
*
L01XE01
ATC
[U] imatinib; oral
+∞
6.3
6
*
1930D
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA MEDULLARE THYREOIDEAE]
+∞
6.3
6
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
6.3
6
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
6.3
6
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
6.3
6
*
C73, C75
ICD-10 Finland
NA
+∞
6.3
6
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
6.3
6
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
6.3
6
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
+∞
6.3
6
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
6.3
6
*
C75.0
ICD-10 Finland
Malignant neoplasm: Parathyroid gland
+∞
6.3
6
*
DQB60
NOMESCO Finland
Aryotenoidectomy
+∞
6.3
6
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
6.3
6
*
C76.0
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Head, face and neck
+∞
6.3
6
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.3
6.2
15
24
R07.0
ICD-10 Finland
Pain in throat
1.7
6.1
121
733
L57.0
ICD-10 Finland
Actinic keratosis
1.7
6.0
115
688
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
2032
22
2939.55
307.65
7.6
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
1727
6550
4.93
307.65
8.3
3.2
ph
7.4
7.4
1.05
364
1105
(4035726)
638
736
10.77
307.65
1.5
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
2012
116
538.68
307.65
7.8
1.1
u/ml
56.9
137.2
0.69
755
34
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
816
1820
5.81
307.65
3.2
3.6
ng/l
48.5
85.6
45.90
734
1556
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2345
11195
6.26
307.65
12.2
5.5
mmol/l
1.2
1.2
40.96
1989
9431
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1748
1603
25.17
307.65
7.2
3.0
pmol/l
4.5
4.5
0.24
1699
1412
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2167
10055
5.30
307.65
10.0
5.0
mmol/l
1.2
1.2
32.86
2079
8895
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
687
356
24.82
307.65
1.5
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1585
7357
3.48
242.73
4.2
2.0
mmol/l
2.3
2.4
43.31
1455
6179
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2794
20196
7.76
193.70
11.5
4.2
pmol/l
17.7
14.7
307.65
2721
18514
(3002256) Pathology report gross observation
626
2076
3.56
154.53
1.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1530
8692
2.57
136.44
2.4
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1260
6557
2.60
134.71
2.4
2.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1726
10517
2.54
130.46
2.8
2.3
nmol/l
79.0
78.3
0.50
1631
9390
(3012095) Magnesium [Moles/volume] in Serum or Plasma
761
3128
2.93
128.54
3.6
2.6
mmol/l
0.8
0.8
1.28
726
2868
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1680
10225
2.49
125.52
4.2
3.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1516
9319
2.28
103.68
5.2
3.8
g/l
36.4
36.1
1.13
1436
8536
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
375
1141
3.62
103.26
4.5
1.5
ug/l
28.5
14.6
0.38
289
850
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
216
446
5.15
99.16
2.5
2.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
828
4020
2.47
96.67
3.6
2.1
mmol/l
2.4
2.4
15.71
752
3430
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2814
23548
4.90
92.18
15.0
4.9
mu/l
1.7
2.1
1.08
2714
21743
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2348
17984
2.47
87.03
9.5
5.5
u/l
75.6
75.0
0.36
2268
16665
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
459
1746
2.93
86.50
7.6
2.8
mmol/l
1.2
1.2
14.55
428
1451
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
925
5021
2.22
81.07
2.2
2.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1629
11074
2.05
77.44
7.2
3.8
umol/l
10.9
11.0
0.14
1561
10314
(3013650) Neutrophils [#/volume] in Blood by Automated count
1806
12917
2.02
72.38
9.5
6.7
e9/l
3.9
4.1
4.75
1584
11159
(3003458) Phosphate [Moles/volume] in Serum or Plasma
556
2666
2.34
63.73
5.3
5.2
mmol/l
1.1
1.0
3.39
516
2457
(40768795) Lymph node Pathology biopsy report
62
51
12.40
62.56
1.2
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
195
566
3.62
56.82
2.3
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1778
13502
1.79
50.13
5.2
4.1
mmol/l
6.5
6.6
1.40
1690
12470
(3033658) Prothrombin time (PT) actual/Normal
873
5443
1.86
47.19
3.8
3.3
%
94.5
92.5
1.81
858
5274
(40768793) Breast Pathology biopsy report
96
214
4.60
40.01
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1189
8564
1.65
36.24
8.3
8.5
inr
1.2
1.2
2.14
378
2541
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
33
30
11.11
31.12
1.2
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
128
435
3.03
28.81
3.1
2.0
u/ml
599.9
77.0
0.84
109
346
(3019550) Sodium [Moles/volume] in Serum or Plasma
2767
25479
2.31
28.75
18.4
13.2
mmol/l
139.8
139.8
0.47
2729
24803
(3044889) 12 lead EKG panel
2032
17166
1.59
28.45
4.2
3.5
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
65
140
4.72
28.28
2.0
1.9
mmol/24h
5.7
9.1
—
8
12
(42870588) Differential panel, method unspecified - Blood
1043
7609
1.57
28.24
6.2
5.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
53
97
5.55
27.72
2.9
2.0
ml
1856.6
1921.2
0.18
47
84
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
172
698
2.55
27.64
1.9
2.0
iu/l
4.9
4.4
0.24
77
260
(3023103) Potassium [Moles/volume] in Serum or Plasma
2769
25569
2.27
27.47
18.7
13.3
mmol/l
3.9
4.0
18.65
2719
24840
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
352
1922
1.94
27.18
5.5
3.0
u/l
232.4
232.7
0.02
333
1800
(40758558) Short blood count panel - Blood
791
5452
1.62
27.02
7.2
4.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
865
6108
1.59
26.63
1.4
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2693
24676
2.01
26.20
17.4
11.5
mg/l
19.8
21.0
1.24
2234
18901
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
380
2160
1.87
25.90
3.3
2.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
384
2191
1.86
25.86
7.5
7.4
mmol/l
1.2
1.3
0.08
308
1680
(3002385) Erythrocyte distribution width [Ratio]
2334
20550
1.64
25.85
21.9
13.7
%
13.6
13.6
0.63
2310
20061
(3002030) Lymphocytes/100 leukocytes in Blood
1422
11266
1.50
25.49
6.4
5.9
%
27.7
28.8
3.45
1334
10427
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
214
994
2.24
25.41
8.9
11.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
385
2213
1.85
25.30
7.4
7.4
kpa
12.6
11.9
1.65
365
2105
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
385
2213
1.85
25.30
7.5
7.4
kpa
5.1
5.1
0.56
365
2110
(3019069) Monocytes/100 leukocytes in Blood
1388
10955
1.50
25.26
6.6
6.1
%
8.5
8.4
0.97
1309
10190
(3006504) Eosinophils/100 leukocytes in Blood
1379
10885
1.50
24.99
6.3
5.8
%
2.8
2.9
1.28
1299
10063
(3019198) Lymphocytes [#/volume] in Blood
1503
12086
1.49
24.79
6.0
5.7
e9/l
1.9
1.9
0.01
1325
10648
(3016502) Oxygen saturation in Arterial blood
348
1955
1.88
24.54
7.6
7.9
%
95.7
95.3
0.39
336
1877
(3022096) Basophils/100 leukocytes in Blood
1338
10538
1.49
24.26
6.4
5.9
%
0.7
0.7
0.55
1258
9746
(3001604) Monocytes [#/volume] in Blood
1457
11721
1.48
23.48
6.0
5.6
e9/l
0.6
0.6
0.13
1258
10136
(3002173) Hemoglobin [Mass/volume] in Arterial blood
321
1793
1.89
22.99
8.0
8.2
g/l
123.7
122.3
0.59
310
1717
(3006315) Basophils [#/volume] in Blood
1460
11782
1.47
22.96
6.0
5.6
e9/l
0.0
0.0
0.93
1262
10176
(3013115) Eosinophils [#/volume] in Blood
1505
12230
1.47
22.75
6.1
5.8
e9/l
0.2
0.2
0.25
1330
10768
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
301
1677
1.88
21.69
1.9
2.1
g/l
0.2
0.2
3.84
290
1524
(3018010) Neutrophils/100 leukocytes in Blood
1387
11176
1.45
21.42
6.2
5.7
%
57.6
56.8
1.72
1303
10379
(3023368) Bacteria identified in Blood by Culture
725
5128
1.55
21.35
4.4
3.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
150
657
2.35
20.43
4.9
7.1
mmol/l
1.3
1.3
0.13
134
569
(3036481) Cortisol [Moles/volume] in Serum or Plasma
367
2218
1.75
20.17
2.6
1.8
nmol/l
385.3
365.1
0.65
344
2014
(3019225) pH of Specimen
372
2288
1.72
19.15
9.4
3.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
94
339
2.83
19.09
2.0
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
218
1143
1.98
18.78
2.2
1.5
u/ml
39.0
25.5
0.83
212
1089
(3039000) Anion gap in Blood
110
439
2.56
18.34
5.4
8.8
mmol/l
11.2
11.3
0.10
102
387
(3018572) Chloride [Moles/volume] in Blood
110
440
2.56
18.26
5.4
8.8
mmol/l
105.9
104.9
2.01
102
388
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
98
373
2.68
17.97
2.0
1.2
nmol/l
0.1
0.4
—
6
22
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2534
23308
1.60
17.73
16.9
10.2
ml/min/173m2
83.5
81.7
4.40
2230
18722
(40761511) CBC panel - Blood by Automated count
2758
25964
1.90
17.60
17.5
11.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2094
18653
1.42
16.02
4.4
4.1
mm/h
12.0
11.4
1.14
1951
17303
(3021589) Normoblasts [#/volume] in Blood
1272
10474
1.38
15.53
11.3
8.0
e9/l
0.0
0.0
0.57
1060
8571
(3008152) Bicarbonate [Moles/volume] in Arterial blood
221
1250
1.83
15.10
6.1
7.2
mmol/l
24.9
24.6
0.87
207
1145
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
198
1083
1.89
15.03
8.0
7.4
mmol/l
25.3
24.8
1.04
193
1078
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
84
329
2.60
14.61
1.9
1.2
nmol/l
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
126
593
2.17
14.52
2.4
3.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
426
2897
1.55
14.41
2.0
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
19
7
27.30
14.26
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
223
1304
1.77
13.63
4.5
5.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
362
2408
1.57
13.46
7.3
6.2
mmol/l
104.2
104.3
0.15
354
2354
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
81
325
2.53
13.44
1.3
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
63
223
2.86
13.33
1.6
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
987
7949
1.36
13.27
3.5
3.4
e6/l
66.1
106.8
1.16
699
5393
(3031040) Bacteria [#/volume] in Urine by Automated count
1800
15876
1.34
13.03
4.7
4.3
e6/l
1914.4
2092.3
0.04
23
201
(3000991) Gas panel - Venous blood
256
1584
1.67
12.75
9.2
7.9
—
—
—
0
0
(3036603) Volume of Urine
44
129
3.45
12.75
1.6
1.4
ml
2170.9
1981.6
—
9
22
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
949
7638
1.36
12.68
3.8
2.7
u/l
28.4
34.0
1.76
902
7237
(3002032) Base excess in Venous blood by calculation
290
1875
1.61
12.13
3.4
3.4
mmol/l
2.1
1.9
0.33
226
1542
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
401
2797
1.50
11.94
2.9
2.5
%
21.7
23.4
1.43
321
2353
(36304419) Bacteria [Presence] in Urine
754
5900
1.37
11.91
3.0
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
561
4185
1.42
11.75
2.5
2.6
mosm/kgh2o
528.5
533.0
0.19
480
3505
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
153
835
1.88
11.73
4.7
5.7
%
1.7
1.6
0.41
145
777
(3018677) aPTT in Platelet poor plasma by Coagulation assay
447
3200
1.47
11.67
2.9
2.0
s
30.0
29.6
0.57
436
3079
(3002582) Erythrocytes [#/volume] in Urine
821
6544
1.35
11.45
3.2
2.9
e6/l
50.3
69.6
0.55
629
4907
(3007930) Methemoglobin/Hemoglobin.total in Blood
151
829
1.87
11.37
4.6
5.8
%
0.9
0.9
0.54
143
774
(3021447) Carbon dioxide [Partial pressure] in Venous blood
286
1880
1.58
11.14
3.4
3.4
kpa
5.9
5.8
0.08
277
1824
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
52
186
2.83
10.86
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
330
2263
1.52
10.61
1.9
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
462
3397
1.43
10.39
2.8
2.4
umol/l
12.7
13.7
2.03
431
3124
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
448
3277
1.43
10.37
2.1
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
60
237
2.56
10.36
1.3
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
425
3085
1.44
10.25
2.7
2.4
g/l
2.4
2.4
0.17
394
2852
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
51
187
2.76
10.19
1.2
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
42
139
3.05
10.08
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
282
1901
1.53
9.81
1.2
1.2
iu/ml
148.0
146.5
0.02
107
743
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1264
10870
1.28
9.79
3.2
2.8
ug/l
107.0
101.3
0.50
1163
10080
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
326
2269
1.49
9.74
1.9
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
726
5801
1.33
9.70
2.4
2.2
mg/l
3.0
2.9
0.77
623
4944
(3030467) Casts [#/volume] in Urine by Automated count
751
6035
1.33
9.64
3.1
2.8
e6/l
0.4
0.4
0.08
573
4465
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
165
982
1.72
9.52
10.9
9.3
mmol/l
24.6
24.5
0.22
157
911
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
572
4425
1.36
9.44
3.9
3.6
ng/l
93.2
445.7
6.81
423
3240
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
587
4569
1.36
9.30
1.5
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
589
4600
1.35
9.11
2.6
2.4
e6/l
4.8
6.5
2.86
511
3975
(40760888) Immunoglobulin light chains.free panel - Serum
88
438
2.04
8.89
3.9
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
872
7226
1.29
8.80
3.0
3.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
85
422
2.04
8.65
3.5
3.7
%
58.2
57.0
0.40
85
422
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
19
40
4.77
8.58
1.4
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
164
1004
1.67
8.55
3.2
2.9
mmol/l
26.0
25.4
1.54
157
969
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
339
2439
1.44
8.52
2.3
2.3
umol/l
7.9
6.7
0.38
298
2067
(3011985) Renin [Units/volume] in Plasma
70
325
2.18
8.48
2.0
1.4
mu/l
37.6
48.3
0.40
59
289
(3005719) IgG [Mass/volume] in Serum or Plasma
246
1664
1.52
8.43
4.0
2.3
g/l
10.7
10.6
0.09
226
1517
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
21
49
4.31
8.40
3.2
2.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
252
1715
1.51
8.39
8.3
6.5
mmol/l
1.2
1.3
1.02
240
1658
(3011412) CD3 cells [#/volume] in Blood
41
149
2.78
8.38
2.6
2.1
e9/l
1.1
1.2
0.22
28
85
(40761536) Microorganisms panel - Urine sediment
279
1944
1.48
8.28
4.1
3.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
56
239
2.37
8.27
4.2
3.0
%
2.2
1.1
1.05
44
179
(3022145) Colonoscopy Study observation
349
2538
1.43
8.27
1.4
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
664
5345
1.31
8.24
4.6
4.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
879
7345
1.28
8.19
2.6
2.3
u/l
59.5
57.3
0.25
809
6718
(3009542) Hematocrit [Volume Fraction] of Blood
2405
22666
1.32
8.01
20.2
12.6
%
39.8
39.8
0.01
1727
16453
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
218
1456
1.54
7.93
1.7
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
262
1819
1.48
7.92
4.1
4.0
%
1.5
0.6
3.09
78
353
(3007853) Bacteria identified in Skin by Aerobe culture
353
2597
1.41
7.83
1.7
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
74
366
2.05
7.65
2.2
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
33
113
2.94
7.54
1.4
1.8
%
17.7
13.1
0.98
14
55
(3021440) Promyelocytes/100 leukocytes in Blood
251
1750
1.47
7.43
4.1
4.1
%
0.2
0.1
1.16
72
326
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
33
115
2.89
7.32
1.8
1.6
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
7
0
+∞
7.29
1.3
0.0
—
—
—
0
0
(3013512) EKG study
812
6799
1.27
7.29
3.5
3.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
195
1298
1.54
7.22
3.0
2.9
g/l
126.8
130.8
1.57
189
1259
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
71
355
2.02
7.15
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
240
1685
1.46
6.87
3.9
3.8
%
1.6
0.5
1.16
49
272
(3020779) Urea [Moles/volume] in Serum or Plasma
238
1671
1.46
6.81
8.8
7.3
mmol/l
9.4
9.6
0.10
222
1594
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
31
109
2.86
6.79
1.4
1.9
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
36
4.46
6.70
1.5
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
261
1873
1.43
6.65
3.6
2.9
ng/l
164.8
171.6
0.11
238
1701
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
76
404
1.90
6.46
2.3
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
105
618
1.72
6.41
4.3
1.5
mg/l
42.0
39.5
0.23
83
500
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
102
596
1.74
6.39
4.1
1.4
ratio
1.1
1.4
—
7
57
(3010421) pH of Blood
90
507
1.80
6.38
4.8
3.6
ph
7.4
7.4
0.21
72
412
(3042631) Mycobacterium sp identified in Specimen
51
236
2.18
6.32
3.6
3.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
226
1599
1.45
6.23
2.6
2.3
e9/l
73.2
71.5
0.23
169
1207
(3027945) Reticulocytes/100 erythrocytes in Blood
294
2182
1.39
6.19
2.8
2.2
%
1.8
1.8
0.03
263
1914
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
104
617
1.71
6.18
4.3
1.5
mg/l
28.4
40.0
0.65
82
497
(3025159) Blasts/100 leukocytes in Blood
236
1686
1.43
6.18
4.0
4.1
%
0.2
0.3
0.16
57
295
(3028626) Oxygen [Partial pressure] in Capillary blood
75
404
1.88
6.14
2.7
2.8
kpa
8.3
8.1
0.30
68
371
(21494815) CD4 cells/100 lymphocytes in Specimen
33
127
2.62
6.13
1.8
2.0
%
40.3
45.1
—
6
18
(3037467) Urinalysis macro (dipstick) panel - Urine
1821
16808
1.22
6.12
4.6
4.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
210
1473
1.46
6.06
2.3
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
93
538
1.75
6.05
1.8
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
65
336
1.96
6.02
5.2
5.6
iu/ml
1170.1
396.6
0.53
11
49
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
458
3650
1.30
5.97
2.7
2.4
e6/l
1.0
1.2
0.95
256
2052
(3012501) Base excess in Blood by calculation
76
416
1.85
5.94
5.3
3.9
mmol/l
2.3
2.5
0.18
55
271
(3024731) MCV [Entitic volume]
2842
27751
1.60
5.92
27.1
17.0
fl
90.1
90.9
19.15
2823
27328
(3007461) Platelets [#/volume] in Blood
2841
27740
1.59
5.91
27.3
17.1
e9/l
258.3
257.3
0.36
2801
27000
(3000963) Hemoglobin [Mass/volume] in Blood
2843
27766
1.60
5.88
27.4
17.1
g/l
135.1
135.4
0.64
2824
27342
(3035941) MCH [Entitic mass]
2842
27754
1.59
5.88
27.1
17.0
pg
30.0
30.2
15.19
2823
27329
(3020630) Protein [Mass/volume] in Serum or Plasma
232
1670
1.42
5.83
3.2
1.5
g/l
66.9
67.1
0.13
214
1497
(3026361) Erythrocytes [#/volume] in Blood
2842
27758
1.59
5.83
27.2
17.1
e12/l
4.5
4.5
3.45
2796
26918
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
420
3321
1.31
5.80
2.8
2.6
e6/l
4.3
3.4
0.58
224
1726
(3010813) Leukocytes [#/volume] in Blood
2842
27761
1.59
5.78
27.3
17.1
e9/l
6.5
6.6
1.46
2799
26920
(3028308) Erythrocytes [#/volume] in Pleural fluid
33
131
2.54
5.78
1.5
1.6
e6/l
28249.5
91743.3
0.68
20
79
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
131
846
1.57
5.61
2.2
2.0
u/l
5871.9
3846.5
0.23
28
356
(3009261) Glucose [Presence] in Urine by Test strip
1347
12145
1.20
5.57
3.8
3.6
estimate
0.0
0.0
1.32
279
2072
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
60
311
1.95
5.54
1.5
1.3
pmol/l
307.7
318.6
0.13
48
241
(3041096) Erythrocytes [Presence] in Urine by Automated
758
6469
1.23
5.50
3.4
3.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
92
547
1.70
5.46
2.9
3.8
u/ml
0.3
0.4
0.49
55
315
(40768800) Prostate Pathology biopsy report
23
78
2.96
5.41
1.1
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
71
394
1.82
5.35
2.5
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
47
226
2.10
5.34
1.1
1.2
u/l
89.2
57.2
0.88
35
152
(3015235) Bicarbonate [Moles/volume] in Capillary blood
84
491
1.73
5.31
3.2
3.2
mmol/l
25.1
24.9
0.15
76
429
(3017446) Testosterone [Moles/volume] in Serum or Plasma
150
1014
1.50
5.24
2.1
2.2
nmol/l
10.8
13.4
3.05
131
890
(3021901) Oxygen saturation in Capillary blood
62
332
1.89
5.23
2.8
2.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1756
16273
1.19
5.20
3.2
2.9
u/l
42.8
41.7
0.26
1635
15126
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
39
176
2.23
5.19
2.0
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
50
249
2.03
5.19
3.5
1.9
u/ml
485.5
113.7
0.39
45
222
(3021601) Nitrite [Presence] in Urine by Test strip
1329
12019
1.19
5.18
5.1
4.8
estimate
0.0
0.0
0.80
277
2112
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
850
7381
1.21
5.15
2.3
2.1
u/l
152.4
197.2
1.34
816
6895
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
54
278
1.96
5.12
2.6
1.5
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
12
27
4.46
5.03
2.4
1.6
pmol/l
42.1
28.5
0.35
12
22
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
12
27
4.46
5.03
1.3
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
58
309
1.89
4.98
1.7
1.4
nmol/l
0.3
0.4
1.64
48
257
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2730
26534
1.37
4.98
12.6
8.8
u/l
24.7
25.2
1.14
2664
25520
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
41
3.67
4.92
1.2
1.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
105
667
1.60
4.86
2.5
1.9
ug/l
16.7
1.8
0.54
90
577
(3028026) IgM [Mass/volume] in Serum or Plasma
184
1315
1.43
4.85
2.5
1.5
g/l
1.4
1.3
0.38
169
1199
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
150
1033
1.48
4.81
2.1
2.0
u/l
35.9
39.3
1.40
131
915
(3052851) Hemolysis interference index of Serum or Plasma
101
638
1.60
4.79
3.3
3.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
68
387
1.77
4.75
1.5
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
265
2020
1.34
4.74
2.6
2.2
u/l
30.2
37.6
1.94
227
1706
(3023199) Leukocytes [#/volume] in Pleural fluid
34
151
2.27
4.73
1.5
1.6
e6/l
1678.6
2799.7
0.65
26
115
(1616796) Gas panel - Central venous blood
71
410
1.75
4.72
4.8
3.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
29
121
2.41
4.63
1.5
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
200
1463
1.39
4.63
3.1
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
69
399
1.75
4.58
2.6
2.4
%
15.8
16.5
0.68
42
202
(21494814) CD8 cells/100 lymphocytes in Specimen
17
54
3.16
4.48
1.3
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1313
11967
1.17
4.43
3.8
3.6
estimate
0.0
0.0
0.00
280
2075
(3007164) IgA [Mass/volume] in Serum or Plasma
582
4937
1.22
4.38
1.7
1.3
g/l
2.3
2.4
0.69
373
2954
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
68
400
1.72
4.28
1.6
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
240
3103
0.75
4.25
4.5
4.6
%
32.5
32.8
0.13
163
2093
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
628
5385
1.21
4.23
2.1
1.8
mg/l
1.1
1.0
0.29
484
4028
(3024980) IgG subclass 4 [Mass/volume] in Serum
66
389
1.71
4.13
2.0
1.7
g/l
0.8
0.8
0.00
46
293
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
295
2330
1.30
4.12
1.4
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
988
8844
1.18
4.08
3.4
3.4
ng/l
47.8
54.9
0.19
633
5604
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
56
316
1.79
4.08
1.8
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
14
42
3.34
4.04
1.4
1.9
e6/l
103.8
175.0
—
8
26
(3045788) Cell count panel - Pleural fluid
28
123
2.29
4.03
1.7
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
135
948
1.44
3.97
3.5
3.8
mmol/l
24.1
24.3
0.24
121
847
(3012441) Differential panel - Pleural fluid
28
125
2.25
3.89
1.6
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
24
100
2.41
3.89
1.5
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
170
1249
1.38
3.88
1.4
1.3
iu/l
31.2
29.3
0.32
149
1094
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
22
88
2.51
3.88
2.1
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
407
3370
1.24
3.84
1.3
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
28
126
2.23
3.83
2.2
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
15
6.02
3.81
5.7
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
21
83
2.54
3.79
5.9
5.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
17
60
2.84
3.79
2.5
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
437
3652
1.23
3.78
1.4
1.3
titre
410.4
570.0
1.69
81
802
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
95
628
1.53
3.78
2.4
2.1
mg/l
10.8
11.2
0.22
88
580
(3017704) Immunofixation for Urine
26
114
2.29
3.78
1.5
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1030
9296
1.17
3.77
4.0
3.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
37
188
1.98
3.72
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
51
289
1.78
3.69
3.3
2.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
43
231
1.87
3.69
2.0
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
90
595
1.53
3.59
2.7
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
696
6124
1.18
3.46
2.7
2.2
umol/l
2386.0
4820.8
1.39
609
5274
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
26
119
2.20
3.44
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
100
2.31
3.43
2.1
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
64
2.67
3.39
1.5
3.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
21
88
2.40
3.39
2.2
1.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
26
120
2.18
3.38
1.2
1.1
u/l
69.6
70.8
0.04
18
84
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
10
7.01
3.36
1.9
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
59
360
1.65
3.32
1.4
1.4
u/ml
101.8
112.9
0.53
16
63
(21494890) Protein electrophoresis panel - 24 hour Urine
33
169
1.96
3.28
1.8
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
301
2455
1.25
3.27
1.7
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
28
136
2.07
3.22
1.6
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
43
243
1.78
3.19
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
62
390
1.60
3.11
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
62
390
1.60
3.11
1.4
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
25
119
2.11
3.04
1.2
1.1
u/l
13.6
14.9
0.13
16
80
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
37
203
1.83
3.03
3.5
1.8
u/ml
5.9
697.0
0.51
37
190
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
769
6884
1.16
3.03
1.8
1.6
mmol/l
1.3
1.4
1.16
643
5805
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
63
401
1.58
3.02
1.3
1.4
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
5
10.01
2.98
9.6
1.0
—
—
—
0
0
(4062490)
43
250
1.73
2.92
1.7
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
43
251
1.72
2.88
1.7
1.4
g/l
2.6
2.9
0.24
28
173
(3024139) IgG subclass 3 [Mass/volume] in Serum
43
251
1.72
2.88
1.7
1.4
g/l
0.3
0.4
0.57
27
173
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24
115
2.10
2.88
3.8
2.3
e6/l
655.4
783.1
0.36
11
50
(3048929) Epstein Barr virus Ab [Presence] in Serum
95
668
1.44
2.87
1.3
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
43
252
1.72
2.85
1.7
1.4
g/l
7.0
6.7
0.23
26
174
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
706
6307
1.16
2.84
3.0
2.9
ng/l
1101.1
1171.0
0.21
602
5323
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
109
2.12
2.84
1.7
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
82
562
1.47
2.83
4.0
2.5
g/l
3.5
3.6
0.29
76
525
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
169
1312
1.31
2.76
2.5
2.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
18
78
2.32
2.74
3.4
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
18
78
2.32
2.74
3.4
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
18
78
2.32
2.74
3.4
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
18
78
2.32
2.74
3.4
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
197
1565
1.28
2.71
3.3
2.8
kpa
4.9
4.6
0.90
188
1517
(3033923) Metanephrine [Moles/time] in 24 hour Urine
16
66
2.43
2.71
1.0
1.2
umol/24h
0.7
0.7
—
9
34
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
45
273
1.66
2.65
2.0
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
128
963
1.34
2.62
2.8
2.4
%
0.7
0.7
0.17
121
922
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
23
113
2.04
2.61
1.7
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
77
531
1.46
2.60
1.5
1.3
u/l
14.0
11.0
0.93
60
436
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
7
15
4.68
2.59
6.9
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
369
3155
1.19
2.55
2.4
2.3
ug/g
112.3
116.0
0.11
289
2484
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
20
94
2.14
2.54
2.9
2.4
%
39.5
46.1
—
6
37
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
85
601
1.43
2.53
2.9
2.3
%
180.1
181.4
0.05
77
566
(3024928) Oxygen saturation in Venous blood
65
436
1.50
2.52
3.3
3.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
39
231
1.70
2.52
2.0
1.3
—
—
—
0
0
(4281824)
28
150
1.87
2.51
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
110
816
1.36
2.48
1.6
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
211
1712
1.25
2.45
2.7
2.7
e9/l
3.9
4.1
0.71
178
1326
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
57
2.46
2.44
1.1
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
149
1159
1.30
2.44
1.5
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
10
34
2.95
2.41
1.2
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
55
360
1.54
2.40
1.3
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2208
21338
1.14
2.40
23.8
14.9
g/l
332.2
332.0
0.41
2198
21204
(3017354) Segmented neutrophils/100 leukocytes in Blood
29
160
1.82
2.39
4.4
2.9
%
55.3
57.7
0.12
16
108
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
129
987
1.32
2.38
2.8
2.5
%
1.0
1.2
1.77
129
977
(3029937) Albumin [Presence] in Urine by Test strip
708
6399
1.14
2.38
4.4
4.0
estimate
0.0
0.0
1.08
268
2105
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
65
443
1.48
2.36
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1087
10094
1.12
2.35
2.0
1.9
pmol/l
95.2
97.6
0.78
538
4994
(3000570) Elastase.pancreatic [Mass/mass] in Stool
91
662
1.39
2.33
1.4
1.4
ug/g
323.7
313.5
0.21
54
359
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
104
775
1.35
2.30
1.6
1.7
g/l
0.2
0.2
1.03
96
729
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
106
793
1.35
2.29
1.6
1.7
g/l
1.2
1.2
0.13
98
743
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
47
301
1.57
2.27
1.3
1.3
—
37.0
—
0
5
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
111
838
1.34
2.26
2.0
1.6
g/l
1.5
1.5
0.06
97
726
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
60
2.34
2.21
1.3
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
9
5.56
2.21
7.6
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
27
150
1.81
2.20
2.9
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
27
150
1.81
2.20
2.9
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
27
150
1.81
2.20
2.9
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
224
1856
1.22
2.18
3.1
2.3
ml/min/173m2
63.7
68.0
0.97
100
715
(46235355) HIV 1 and 2 tests - Meaningful Use set
449
3958
1.16
2.16
1.8
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
20
101
1.99
2.15
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
544
4863
1.15
2.15
1.4
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
34
204
1.67
2.14
1.3
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
203
1668
1.23
2.14
1.3
1.3
au/ml
62.4
46.0
0.30
11
75
(40768443) Skin Pathology biopsy report
124
960
1.30
2.13
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
648
5866
1.13
2.11
1.3
1.3
u/ml
2.0
1.8
0.20
176
1605
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
89
657
1.37
2.11
2.6
2.1
%
94.9
93.0
0.39
84
607
(3035880) pH of Pleural fluid
15
68
2.21
2.11
1.3
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
82
600
1.38
2.06
3.9
4.0
mmol/l
3.8
3.9
0.23
76
569
(3021960) Folate [Moles/volume] in Serum or Plasma
611
5523
1.13
2.04
1.5
1.5
nmol/l
21.8
21.1
0.20
544
4685
(3006184) Hemoglobin [Mass/volume] in Capillary blood
66
466
1.43
2.04
2.4
2.2
g/l
122.9
131.2
1.63
55
337
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
6
15
4.01
2.04
1.3
1.0
nmol/l
0.4
0.3
—
6
8
(40758292) HTLV I+II Ab panel - Serum
6
15
4.01
2.04
2.2
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
104
792
1.32
2.03
2.8
1.4
g/l
9.8
10.4
0.70
80
657
(3036489) Thrombin time
106
810
1.32
2.02
2.4
1.9
s
21.5
20.9
0.44
92
688
(3045414) Leukocytes [Presence] in Urine
84
1125
0.74
2.02
2.0
1.9
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
25
140
1.79
2.00
1.6
1.5
u/l
7.8
7.0
—
10
60
(3020891) Body temperature
108
830
1.31
1.98
4.6
4.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
185
1519
1.23
1.98
1.4
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
219
1832
1.21
1.96
2.4
2.4
au/ml
17.8
23.7
0.64
18
107
(3022475) Manganese [Moles/volume] in Blood
5
11
4.55
1.94
1.2
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
35
218
1.61
1.94
2.6
2.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
508
4555
1.14
1.92
5.4
3.7
ug/l
2.2
1.9
1.41
457
4091
(40768441) Liver Pathology biopsy report
24
135
1.78
1.91
1.0
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
17
85
2.01
1.90
1.1
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
52
2.31
1.87
1.3
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
9
34
2.65
1.86
1.0
1.1
umol/24h
1.5
1.7
—
9
34
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
15
72
2.09
1.86
1.2
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
11
46
2.40
1.85
1.2
1.5
ng/l
63.8
108.2
1.40
11
46
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
97
745
1.31
1.81
1.1
1.1
u/ml
2.2
5.6
1.27
15
89
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
109
851
1.29
1.81
2.8
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
214
1802
1.20
1.81
1.3
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
109
852
1.29
1.79
2.8
1.4
g/l
3.8
3.8
0.10
71
597
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
109
852
1.29
1.79
2.8
1.4
g/l
7.4
7.4
0.01
74
626
(3000494) Fungus identified in Specimen by Culture
323
2819
1.16
1.79
1.7
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
589
5356
1.12
1.78
4.3
4.1
kg/l
1.0
1.0
0.01
109
759
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
154
0.39
1.75
1.3
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
17
88
1.94
1.74
1.0
1.2
%
122.8
111.8
0.91
17
77
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
76
567
1.35
1.74
1.3
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
36
2.50
1.74
1.7
1.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
55
390
1.42
1.71
1.2
1.4
mmol/l
62.8
64.6
0.10
40
321
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
48
332
1.45
1.70
1.4
1.2
u/l
16.7
22.1
0.64
42
284
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
79
597
1.33
1.67
1.3
1.2
u/ml
14.9
43.0
—
9
71
(1002224) Polysomnography panel
129
1042
1.25
1.65
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
23
135
1.71
1.62
1.5
1.8
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
14
3.58
1.61
7.8
3.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
75
982
0.76
1.60
1.4
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
579
5295
1.12
1.59
1.6
1.7
pmol/l
453.5
39950637.7
5.26
462
4418
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
26
2.70
1.58
2.0
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
28
175
1.61
1.57
7.0
3.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
36
239
1.51
1.57
1.6
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
101
800
1.27
1.54
2.9
1.4
g/l
3.1
3.0
0.08
74
611
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
33
2.43
1.53
1.5
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
33
2.43
1.53
1.5
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
33
2.43
1.53
1.5
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
15
3.34
1.52
1.0
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
17
93
1.83
1.51
1.2
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
57
417
1.37
1.51
1.4
1.2
u/ml
301.8
252.2
0.66
34
257
(3024891) Influenza virus A+B Ag [Presence] in Specimen
76
583
1.31
1.48
1.1
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
28
2.50
1.45
1.1
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
54
395
1.37
1.44
1.3
1.4
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
5
16
3.13
1.44
7.8
3.6
mg/l
22.6
22.3
—
5
16
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
152
0.46
1.43
11.6
17.1
nmol/l
987.7
1472.9
—
7
147
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2455
24988
0.90
1.42
4.4
4.4
mmol/l
1.5
1.5
5.16
2289
23169
(3025941) Bacteria identified in Stool by Culture
166
1403
1.19
1.40
1.3
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
27
173
1.57
1.40
2.0
2.3
%
11.0
11.2
0.09
27
173
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
53
2.08
1.38
5.8
2.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
67
511
1.32
1.38
1.6
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
405
3661
1.12
1.38
4.5
3.6
%
22.4
23.9
1.39
209
1630
(3017509) Phencyclidine [Presence] in Urine
6
23
2.61
1.36
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
243
2125
1.16
1.36
1.2
1.2
—
—
—
0
0
(44790047)
31
207
1.50
1.35
1.7
1.4
—
—
—
0
0
(44790048)
31
207
1.50
1.35
1.7
1.4
—
—
—
0
0
(44790049)
31
207
1.50
1.35
1.7
1.4
—
—
—
0
0
(44806118)
31
207
1.50
1.35
1.7
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29
191
1.52
1.34
2.8
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2367
24119
0.91
1.33
3.9
3.9
mmol/l
1.3
1.3
0.43
2191
22191
(3015171) Extractable nuclear Ab [Units/volume] in Serum
136
1136
1.21
1.32
1.3
1.3
u/ml
2.4
0.9
0.33
12
105
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
34
233
1.46
1.31
1.4
1.2
ug/l
1.7
2.7
1.62
28
204
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
149
0.47
1.31
9.1
12.4
nmol/l
569.0
827.0
—
7
142
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
24
2.50
1.30
5.5
10.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
41
566
0.72
1.29
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
84
1049
0.79
1.29
1.4
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
31
210
1.48
1.27
1.4
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
806
7574
1.09
1.27
3.2
3.2
mmol/l
7.2
7.2
0.11
681
6392
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
26
170
1.53
1.26
2.9
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
60
458
1.32
1.25
1.6
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
83
662
1.26
1.25
1.2
1.2
titre
80.0
84.3
0.10
11
61
(3032868) Hemoglobin electrophoresis panel in Blood
6
25
2.40
1.24
1.8
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
36
2.23
1.24
2.1
3.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
96
781
1.24
1.22
1.4
1.3
u/ml
12.7
45.5
—
7
45
(3050129) First trimester maternal screen panel - Serum or Plasma
47
628
0.74
1.22
1.4
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
56
1.97
1.22
4.8
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
56
1.97
1.22
4.8
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
56
1.97
1.22
4.8
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2476
25149
0.91
1.21
4.5
4.4
mmol/l
4.7
4.8
2.26
2325
23447
(3045424) Erythrocytes [Presence] in Urine
28
408
0.68
1.21
1.7
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
194
1687
1.16
1.20
1.3
1.3
u/ml
105.3
200.4
2.94
177
1557
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
69
541
1.28
1.20
1.4
1.3
e6/l
41.8
29.4
0.25
44
422
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
109
1.66
1.18
1.6
1.7
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
69
542
1.28
1.18
1.4
1.4
e6/l
1078.9
1432.0
0.17
50
448
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
361
3274
1.12
1.18
1.7
1.6
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
2.4
—
43.0
—
0
27
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
31
215
1.45
1.15
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
209
2367
0.87
1.11
1.3
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
30
209
1.44
1.10
1.3
1.2
u/ml
0.2
0.9
0.76
16
90
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2522
25567
0.91
1.08
5.0
4.9
mmol/l
2.8
2.8
0.46
2353
23714
(3019309) Folate [Moles/volume] in Red Blood Cells
473
4378
1.10
1.05
1.8
1.7
nmol/l
1170.9
1171.0
0.00
377
3323
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
67
1.79
1.04
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
51
393
1.30
1.04
1.4
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
22
2.27
1.03
2.4
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
22
2.27
1.03
4.8
6.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
49
376
1.31
1.03
1.2
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
47
1.92
1.02
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
44
575
0.76
1.02
1.9
2.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
53
1.89
1.01
1.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
150
1300
1.16
1.01
4.1
3.5
kpa
5.2
5.2
0.05
137
1200
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
106
0.47
1.01
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
35
256
1.37
1.00
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
148
1283
1.16
0.99
4.1
3.5
ph
7.4
7.4
0.26
32
143
(3000330) Specific gravity of Urine by Test strip
101
1197
0.84
0.98
3.2
3.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
49
379
1.30
0.98
1.2
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
29
0.00
0.97
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
222
0.63
0.94
1.3
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
119
0.50
0.93
1.8
5.8
—
55.4
—
0
29
(37021550) Renin [Units/volume] in Plasma --upright
10
55
1.82
0.92
1.4
1.2
mu/l
102.5
62.0
—
10
39
(3037121) Protein [Mass/volume] in Urine
86
718
1.20
0.91
3.9
2.6
g/l
0.2
0.3
2.84
38
223
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
255
2811
0.90
0.90
1.6
1.7
%
1.4
1.4
0.53
220
2496
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
284
2587
1.11
0.90
3.1
2.6
ug/l
0.7
0.7
0.34
200
1648
(3044007) Cell count panel - Peritoneal fluid
8
42
1.91
0.88
1.9
2.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
37
280
1.33
0.88
1.8
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
27
194
1.40
0.88
1.5
2.2
u/field
2.0
2.1
0.04
11
87
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
31
415
0.74
0.87
1.6
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
56
1.79
0.87
3.5
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
43
1.86
0.87
1.5
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
30
2.00
0.87
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
745
7084
1.07
0.86
3.3
3.2
mg/l
1077.5
302.6
1.90
448
4267
(3021387) Prolactin [Units/volume] in Serum or Plasma
97
825
1.18
0.85
1.7
1.6
mu/l
314.5
304.8
0.11
91
737
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
76
632
1.21
0.85
2.7
1.4
g/l
0.0
0.0
0.35
66
580
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
141
1236
1.15
0.85
4.1
3.4
mmol/l
2.6
1.8
2.68
114
914
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
31
1.94
0.84
1.5
2.4
u/field
1.3
0.8
—
6
31
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
71
589
1.21
0.82
2.8
1.4
g/l
0.0
0.0
0.00
61
539
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
47
373
1.26
0.81
1.1
1.0
u/ml
2.0
2.9
0.46
30
174
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
100
858
1.17
0.80
1.6
2.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
47
1.70
0.80
1.1
1.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
70
582
1.21
0.80
2.8
1.4
g/l
0.0
0.0
0.00
61
538
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
41
520
0.79
0.80
1.3
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
48
383
1.26
0.79
1.4
1.2
u/ml
5.2
5.6
0.07
23
153
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
49
392
1.25
0.79
1.4
1.2
u/ml
2.2
3.4
0.58
17
121
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.2
—
30.4
—
0
7
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
41
519
0.79
0.79
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
41
519
0.79
0.79
1.3
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
49
393
1.25
0.78
1.9
2.8
umol/l
24.6
35.9
3.63
43
345
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
41
518
0.79
0.78
1.3
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
84
713
1.18
0.77
3.3
1.4
g/l
0.7
0.4
0.20
69
613
(3035320) C reactive protein [Mass/volume] in Body fluid
23
165
1.40
0.77
1.9
2.4
—
—
—
0
0
(4146454)
19
269
0.70
0.77
2.3
2.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
27
0.00
0.77
0.0
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
26
191
1.36
0.77
4.5
4.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
24
174
1.38
0.76
1.3
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
25
183
1.37
0.75
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
59
486
1.22
0.75
1.4
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1644
16057
1.05
0.73
3.2
3.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
106
0.57
0.72
1.2
9.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
84
719
1.17
0.72
1.4
1.3
u/ml
3.6
5.8
0.58
15
119
(40768446) Kidney Pathology biopsy report
13
84
1.55
0.71
1.5
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
40
1.75
0.71
1.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
57
1.58
0.71
1.4
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
15
101
1.49
0.70
3.9
1.5
u/l
190.6
190.3
0.01
15
101
(3022217) INR in Platelet poor plasma by Coagulation assay
306
2839
1.09
0.70
20.4
24.4
inr
1.1
1.3
2.05
56
430
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
41
1.71
0.70
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
35
274
1.28
0.69
1.9
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
27
1.85
0.68
4.2
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
35
275
1.28
0.68
1.9
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
22
161
1.37
0.68
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
41
329
1.25
0.67
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
21
153
1.38
0.67
1.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
28
1.79
0.66
1.4
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
82
709
1.16
0.64
1.4
1.3
u/ml
1.8
6.7
—
10
71
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
22
163
1.35
0.64
1.2
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
39
481
0.81
0.63
1.4
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
52
432
1.21
0.63
1.2
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
89
1019
0.87
0.63
2.1
1.7
mg/l
3.4
3.7
0.13
61
713
(3014148) Varicella zoster virus Ab [Titer] in Serum
36
287
1.26
0.63
1.3
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
146
1.37
0.63
1.1
1.1
u/l
1.1
1.1
—
9
74
(3016750) Collection duration of Urine
18
129
1.40
0.63
1.9
2.2
min
482.1
501.3
0.44
13
102
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
87
1.50
0.63
1.2
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
44
535
0.82
0.63
2.0
2.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
140
1555
0.90
0.62
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
210
2284
0.91
0.62
1.8
1.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
63
1.59
0.61
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
217
1.29
0.61
1.2
1.1
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.0
—
0
11
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.3
—
0
14
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
15
105
1.43
0.60
3.4
2.0
ug/l
22.0
94.2
0.48
15
95
(4268621)
33
263
1.26
0.59
2.2
2.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
52
1.54
0.59
1.0
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
91
800
1.14
0.58
1.7
1.6
iu/ml
0.4
0.1
0.32
23
159
(3023410) Appearance of Cerebral spinal fluid
29
228
1.27
0.58
1.6
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
164
1495
1.10
0.57
1.7
1.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
15
106
1.42
0.57
2.1
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
54
1.48
0.57
1.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
81
1.48
0.57
2.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
81
1.48
0.57
2.0
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
81
1.48
0.57
1.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
36
1.67
0.56
3.2
2.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
37
451
0.82
0.56
1.4
1.5
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
86
0.58
0.56
4.0
2.6
umol/l
34.4
29.2
—
5
60
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
240
2580
0.92
0.56
1.9
1.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
89
0.56
0.56
1.0
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
6
37
1.62
0.55
1.5
1.8
g/l
13.7
10.7
—
6
26
(3047352) Trisomy 18 risk [Likelihood] in Fetus
36
439
0.82
0.55
1.3
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
9
60
1.50
0.54
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
32
394
0.81
0.54
1.1
1.1
iu/ml
50.0
1522.2
—
6
87
(3015183) Erythrocyte sedimentation rate
17
125
1.36
0.53
1.3
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
36
437
0.82
0.53
1.3
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
80
703
1.14
0.53
1.4
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
38
313
1.22
0.53
1.8
1.5
%
63.8
59.3
0.28
23
193
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
39
1.54
0.53
1.2
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
39
1.54
0.53
1.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
9
62
1.45
0.53
1.0
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
773
7467
1.05
0.52
4.1
4.0
mg/mmol
11.0
8.0
0.65
461
4541
(3051611) Lipemic interference index of Serum or Plasma
26
205
1.27
0.52
5.4
3.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
30
241
1.25
0.52
1.2
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
100
1.40
0.51
1.0
1.1
—
—
—
0
0
(4198724)
12
83
1.45
0.51
2.5
1.9
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
40
1.50
0.51
1.2
3.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
203
0.74
0.51
1.4
1.4
mmol/l
11.4
11.6
—
6
50
(3016650) Hepatitis A virus Ab [Presence] in Serum
46
388
1.19
0.51
1.2
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
65
1.39
0.50
4.2
5.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
47
398
1.18
0.50
3.2
3.2
nmol/l
0.8
0.8
0.11
39
303
(3033799) Differential panel - Peritoneal fluid
6
41
1.46
0.50
3.5
2.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
313
0.80
0.49
1.1
1.1
u/ml
0.6
3.3
—
7
125
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
130
1184
1.10
0.49
1.5
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
45
1.56
0.49
2.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
121
1330
0.91
0.48
1.4
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
155
0.71
0.48
1.2
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
46
1.52
0.48
1.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
151
1387
1.09
0.48
1.1
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
74
653
1.14
0.48
1.4
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
175
1620
1.09
0.47
3.1
2.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
48
1.46
0.46
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
24
191
1.26
0.46
2.7
2.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
76
675
1.13
0.45
2.9
1.4
g/l
38.6
38.0
0.43
64
566
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
54
468
1.16
0.45
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77
685
1.13
0.45
1.2
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
29
352
0.82
0.45
1.4
1.5
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
24
192
1.25
0.45
1.2
1.2
mg/l
29.2
33.6
0.37
19
160
(4027681)
19
148
1.29
0.43
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
37
312
1.19
0.43
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
185
1982
0.93
0.43
3.9
3.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
67
593
1.13
0.43
1.6
1.6
e6/l
18059.0
10757.0
0.58
53
433
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
31
1.61
0.43
1.0
1.2
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
5
32
1.56
0.42
1.6
1.3
—
90.3
—
0
11
(3011397) Hemoglobin [Presence] in Urine by Test strip
591
5708
1.04
0.42
3.9
3.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2336
23151
1.04
0.41
5.8
5.6
mmol/mol
39.2
39.4
0.56
2183
21531
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
23
283
0.81
0.41
1.0
1.0
u/ml
0.2
0.3
—
5
73
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
96
871
1.11
0.41
1.8
1.9
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
11
150
0.73
0.41
1.4
1.4
—
597.3
—
0
15
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
2.7
—
4.1
—
0
15
(3007542) Rye IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.2
—
0
7
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
16
0.00
0.41
0.0
1.4
—
2.3
—
0
16
(3000012) Reticulocyte production index
14
105
1.33
0.41
1.4
1.5
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
2.4
—
0
8
(3026480) Teichoate Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
114
1.32
0.40
1.3
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
88
1.37
0.40
1.2
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
32
269
1.19
0.39
1.5
1.8
—
1792.0
—
0
5
(3014765) Yersinia sp identified in Stool by Organism specific culture
82
740
1.11
0.39
1.2
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
0.0
—
0
10
(3014599) Egg white IgE Ab [Units/volume] in Serum
10
137
0.73
0.39
1.1
1.0
u/ml
0.3
0.5
—
5
36
(3028433) Virus identified in Specimen by Culture
9
67
1.34
0.38
1.1
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
30
355
0.84
0.37
1.5
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
68
1.32
0.37
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
109
1002
1.09
0.37
1.7
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
134
1.27
0.37
1.3
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
28
235
1.19
0.36
2.2
2.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
144
1.25
0.35
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
82
748
1.10
0.34
1.2
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
82
1.34
0.34
1.8
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
82
1.34
0.34
1.8
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
145
1.24
0.33
1.0
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
27
228
1.19
0.33
1.8
1.4
%
35.8
33.7
0.10
15
137
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
43
378
1.14
0.33
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
31
266
1.17
0.32
2.0
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
17
209
0.81
0.32
1.2
1.4
nmol/l
1.4
1.5
0.13
17
190
(3014133) Dog dander IgE Ab [Units/volume] in Serum
30
348
0.86
0.31
1.0
1.1
u/ml
1.9
2.6
—
9
131
(3025468) Yersinia sp identified in Specimen by Organism specific culture
31
267
1.16
0.31
2.0
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
17
208
0.82
0.31
1.4
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
92
849
1.09
0.31
2.7
1.8
—
—
—
0
0
(4010399)
172
1817
0.94
0.30
1.4
1.4
—
—
—
0
0
(3019977) pH of Arterial blood
13
102
1.28
0.30
1.6
2.8
ph
7.4
7.4
—
5
30
(3005988) Vibrio sp identified in Specimen by Organism specific culture
31
269
1.15
0.29
2.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
110
0.73
0.28
2.5
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
103
1.26
0.28
7.4
4.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
118
0.76
0.27
1.1
1.5
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
42
375
1.12
0.27
1.1
1.1
u/ml
0.1
2.0
—
7
96
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
73
672
1.09
0.27
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
42
376
1.12
0.26
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
214
0.84
0.26
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
214
0.84
0.26
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
214
0.84
0.26
1.3
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
25
288
0.87
0.25
1.2
2.0
umol/l
3.6
4.8
0.90
16
199
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
32
282
1.14
0.25
1.2
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
15
123
1.22
0.25
1.3
1.4
pmol/l
133.7
286.1
—
8
41
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
213
0.84
0.25
1.3
1.2
—
—
—
0
0
(4034850)
92
860
1.07
0.24
12.5
9.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
20
170
1.18
0.24
1.1
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
133
1.20
0.24
1.3
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
82
0.73
0.24
1.0
1.5
ug/l
7.2
8.6
—
6
82
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
79
735
1.08
0.24
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
212
0.85
0.24
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
212
0.85
0.24
1.3
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
38
341
1.12
0.23
1.1
1.3
mmol/l
7.8
7.6
0.17
28
256
(3008898) HLA-B27 [Presence]
100
940
1.07
0.23
1.1
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
124
1176
1.06
0.22
1.7
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
82
767
1.07
0.22
1.4
1.3
miu/ml
228.5
217.4
0.10
42
381
(21494434) Karyotype in Bone marrow
18
153
1.18
0.22
1.1
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
42
462
0.91
0.22
1.7
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
238
1.14
0.22
1.1
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
107
1.22
0.21
1.7
2.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
42
1.19
0.21
1.2
1.8
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
11
0.00
0.21
0.0
3.9
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
37
334
1.11
0.21
1.5
1.2
—
—
—
0
0
(3000492) Spirometry study
244
2357
1.04
0.21
1.5
1.4
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
7
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
12.6
—
0
12
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
15
126
1.19
0.21
1.0
1.2
u/l
176.3
323.8
0.87
15
112
(3007463) Buprenorphine [Presence] in Urine
0
13
0.00
0.21
0.0
4.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
24.4
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
45
412
1.09
0.20
1.9
1.7
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.1
—
0
7
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
12
144
0.83
0.19
1.2
1.7
mmol/l
9.4
7.9
—
6
86
(4024509)
23
260
0.88
0.19
1.7
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
51
1.18
0.19
1.0
1.1
u/ml
136.8
44.9
—
6
51
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
111
1056
1.05
0.19
1.3
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
121
0.83
0.18
2.0
1.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
61
1.15
0.17
1.4
3.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
61
1.15
0.17
1.4
3.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
83
786
1.06
0.17
2.2
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
25
278
0.90
0.17
1.4
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
21
236
0.89
0.16
4.4
2.9
mg/l
43.4
22.9
0.34
16
163
(3029075) Extractable nuclear Ab panel - Serum
8
68
1.18
0.16
1.3
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
30
273
1.10
0.16
1.7
2.3
mg/l
38.9
24.5
—
10
68
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
223
2295
0.97
0.16
1.7
1.7
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
37
341
1.09
0.15
1.4
1.3
u/ml
51.9
35.3
—
5
18
(3028707) Methadone [Presence] in Urine by Screen method
32
349
0.92
0.15
2.1
2.7
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
15
130
1.15
0.15
1.5
1.5
ug/l
6.9
8.4
0.36
15
107
(3006442) Creatine [Moles/volume] in Serum or Plasma
20
178
1.12
0.15
1.5
1.6
—
68.4
—
0
16
(3029634) Reagin Ab [Titer] in Serum by VDRL
35
323
1.08
0.14
1.6
1.9
—
4.0
—
0
6
(4094501)
67
706
0.95
0.14
1.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
16
181
0.88
0.14
1.0
1.0
ng/l
35.1
51.0
0.63
11
117
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
100
0.80
0.13
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
59
559
1.06
0.13
2.8
2.4
ug/min
161.6
102.8
0.34
36
344
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
60
569
1.06
0.13
1.3
1.2
u/ml
15.0
3.7
—
8
43
(1001926) Buprenorphine [Presence] in Urine by Screen method
58
611
0.95
0.12
1.8
2.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
50
529
0.94
0.12
2.8
3.5
mg/l
35.0
24.0
0.65
26
328
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
39
365
1.07
0.12
1.1
1.1
%
124.6
117.9
0.54
34
330
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
11
95
1.16
0.11
1.4
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
468
4615
1.02
0.11
1.3
1.3
u/ml
15.6
12.2
0.39
172
1844
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
16
178
0.90
0.11
1.0
1.0
ng/l
875.1
720.2
0.43
11
114
(3022313) Gas panel - Capillary blood
98
946
1.04
0.11
4.4
3.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
69
719
0.96
0.10
1.7
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
900
9075
0.99
0.10
2.8
2.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
16
177
0.90
0.10
1.0
1.0
ng/l
283.7
365.4
0.60
11
117
(3002619) Bacteria identified in Specimen by Culture
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
36
381
0.94
0.09
1.6
1.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
10
87
1.15
0.09
1.9
1.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
57
1.05
0.08
1.2
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2465
24599
1.01
0.08
4.8
4.5
mmol/l
5.9
5.9
0.60
2293
22580
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
295
2909
1.02
0.08
1.6
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
117
1.11
0.08
1.2
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
66
1.06
0.08
1.4
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
303
3071
0.99
0.08
7.8
6.1
—
—
—
0
0
(4211845)
14
127
1.10
0.08
2.0
3.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
6
72
0.83
0.07
1.2
1.0
—
3.4
—
0
11
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
77
1.04
0.07
1.3
2.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
112
0.89
0.07
1.2
1.1
miu/ml
1950.3
1603.7
—
10
112
(3037556) Urate [Mass/volume] in Serum or Plasma
7
80
0.87
0.07
1.7
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
82
0.85
0.07
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
76
782
0.97
0.07
1.7
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
37
387
0.96
0.07
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
90
0.89
0.06
1.4
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
11
99
1.11
0.06
1.5
2.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
40
384
1.04
0.06
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
45
466
0.97
0.05
1.4
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
43
415
1.04
0.05
1.1
1.1
u/ml
3.5
4.7
0.46
27
215
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
196
1935
1.01
0.05
2.0
2.3
ug/l
7.8
6.9
0.17
169
1689
(3027008) Opiates [Presence] in Urine
76
778
0.98
0.05
1.7
2.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
38
366
1.04
0.05
1.7
1.4
u/l
32.4
28.0
0.27
30
280
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
159
1.07
0.05
1.3
1.1
ratio
1.0
1.0
—
5
60
(3019832) Treponema pallidum Ab [Presence] in Serum
205
2026
1.01
0.05
1.6
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
201
0.94
0.04
1.7
1.2
—
—
—
0
0
(4306422)
37
383
0.97
0.04
1.2
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
20
211
0.95
0.04
1.5
1.4
g/l
1.0
1.0
0.39
20
211
(3014271) Vancomycin [Susceptibility]
10
109
0.92
0.04
2.7
3.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
29
279
1.04
0.04
1.5
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
76
774
0.98
0.03
1.7
2.0
—
—
—
0
0
(44813793)
17
179
0.95
0.03
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
19
181
1.05
0.03
2.1
2.4
ml
606.4
630.4
0.07
13
129
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
49
479
1.02
0.03
2.1
2.0
nmol/l
0.9
0.8
0.57
38
395
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
479
4811
0.99
0.03
1.3
1.3
iu/ml
40.4
33.3
0.32
154
1509
(3032773) Endomysium IgG Ab [Titer] in Serum
20
209
0.96
0.03
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
15
142
1.06
0.02
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
162
1.05
0.02
1.1
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
15
143
1.05
0.01
1.0
1.0
u/ml
0.3
0.9
—
8
49
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
17
177
0.96
0.01
1.5
1.3
—
1.6
—
0
12
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
48
473
1.02
0.01
1.0
1.1
u/ml
1.3
1.5
0.17
25
186
(3027944) Amphetamines [Presence] in Urine
76
767
0.99
0.01
1.7
2.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
106
0.94
0.01
1.3
1.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
12
114
1.05
0.00
2.1
3.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
15
155
0.97
0.00
1.0
1.1
iu/ml
5.4
12.1
—
5
37
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
99
1.01
0.00
1.8
2.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
121
0.99
0.00
1.2
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
13
129
1.01
0.00
1.1
1.3
nmol/l
123.2
137.0
1.41
13
129
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
13
129
1.01
0.00
1.6
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
149
1.01
0.00
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
56
561
1.00
0.00
3.7
4.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
116
1.03
0.00
1.1
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
40
402
0.99
0.00
1.0
1.1
u/ml
0.8
0.9
0.12
24
171
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
117
1.03
0.00
1.0
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
23
227
1.01
0.00
1.1
1.2
nmol/l
367.7
386.0
0.15
18
205
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
137
1.02
0.00
1.1
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
690.5
—
0
7
(3032057) Clostridioides difficile [Presence] in Stool
5
51
0.98
0.00
1.8
1.8
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
4.5
—
0
6
(40763590) HLA-DQ beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017400) Magnesium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
2.1
—
0
5
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
6
62
0.97
0.00
4.8
2.3
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
88
0.91
0.00
1.4
1.5
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
59
1.02
0.00
1.0
1.3
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
162.6
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
62
0.97
0.00
1.3
1.6
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
6
65
0.92
0.00
1.2
1.3
umol/l
16.3
17.0
—
6
60
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
89
0.90
0.00
1.1
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_THYROID_GLAND_EXALLC – Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
GWS hits: 18
This endpoint is excluded (different definition than used in FinnGen).